|
UBA6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.937500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.138500E-02 |
| Normal-vs-Stage2 |
6.247900E-04 |
| Normal-vs-Stage3 |
7.997900E-03 |
| Normal-vs-Stage4 |
2.883800E-03 |
| Stage1-vs-Stage2 |
4.140000E-02 |
| Stage1-vs-Stage3 |
2.735800E-01 |
| Stage1-vs-Stage4 |
1.646360E-01 |
| Stage2-vs-Stage3 |
3.108800E-01 |
| Stage2-vs-Stage4 |
5.680400E-01 |
| Stage3-vs-Stage4 |
6.573800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.875400E-03 |
| Normal-vs-AfricanAmerican |
5.766800E-01 |
| Normal-vs-Asian |
3.437700E-02 |
| Caucasian-vs-AfricanAmerican |
2.165800E-01 |
| Caucasian-vs-Asian |
9.963200E-01 |
| AfricanAmerican-vs-Asian |
2.864600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.182400E-03 |
| Normal-vs-Female |
6.658100E-03 |
| Male-vs-Female |
5.768400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.012200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.170300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.455210E-03 |
| Normal-vs-Age(81-100Yrs) |
5.495000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.180060E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.709780E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.702200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.219200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.339400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.152200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.360000E-01 |
| Classical-VS-Follicular |
1.832580E-04 |
| Classical-VS-Other |
2.555200E-01 |
| Classical-VS-Normal |
5.039500E-02 |
| Tall-VS-Follicular |
7.970100E-02 |
| Tall-VS-Other |
4.501000E-01 |
| Tall-VS-Normal |
1.734410E-01 |
| Follicular-VS-Other |
8.990000E-01 |
| Follicular-VS-Normal |
6.2487E-05 |
| Other-VS-Normal |
6.725900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.406800E-04 |
| Normal-vs-N1 |
2.153900E-02 |
| N0-vs-N1 |
3.319600E-01 |
|
|
